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A B S T R A C T
Introduction: Previous investigations found elevated mortality after breast cancer in association with biomarkers
of persistent organochlorine pesticides in non-occupationally exposed women. We hypothesized that lifetime
residential pesticide use, which includes persistent and non-persistent pesticides, would also be associated with
increased mortality after breast cancer.
Methods: A population-based cohort of 1505 women with invasive or in situ breast cancer was interviewed in
1996–1997, shortly after diagnosis, about pre-diagnostic lifetime residential pesticide use. Participants were
followed for mortality through 2014 (595 deaths from any cause and 236 from breast cancer, after 17.6 years of
follow-up). Pesticides were examined as 15 individual categories; a group of seven used for lawn and garden
purposes; a group of eight used for nuisance-pest purposes; and all combined. Cox regression was used to es-
timate hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and breast cancer-specific mortality.
Modification by estrogen receptor (ER) status, body mass index, and long-term residence was examined.
Results: Ever use (HR=0.77, 95%CI=0.63–0.95) and higher lifetime applications (4th quartile: HR=0.62,
95%CI=0.47–0.81, ptrend= 0.3) of the lawn and garden group of pesticides were inversely associated with all-
cause mortality, compared to never use. The inverse association for lawn and garden pesticide use was limited to
ER positive (vs. negative) tumors (pinteraction= 0.05). Nuisance-pest pesticides, and all groups combined, were
not associated with all-cause or breast cancer-specific mortality.
Conclusions: Contrary to our hypothesis, lifetime residential use of lawn and garden pesticides, but not all
combined or nuisance-pest pesticides, was inversely associated with all-cause mortality after breast cancer.
1. Introduction
According to the most recent estimates in the United States (US),
over 3.3 million women are living with breast cancer (National Cancer
Institute, 2017) and 40,920 deaths were estimated to occur from this
disease in 2018 (Siegel et al., 2018). A number of modifiable risk factors
have been established for the development of breast cancer, but fewer
have been identified for survival after getting the disease. Pesticides are
a common environmental exposure encompassing herbicides, in-
secticides, rodenticides, and fungicides and their use can be modified by
individual action or regulation. The Environmental Protection Agency
estimated that in 1996, the first enrollment year of our study cohort,
1229 million tons of total pesticide active ingredients were used in the
US, including 130 million tons on homes and gardens (Grube et al.,
2011).
Pesticides can be categorized as persistent versus non-persistent.
Persistent pesticides are those that bioaccumulate in the environment
and have long biological half-lives, between 5 and 15 years in humans
(Genuis et al., 2016; Wolff, 1999; Wolff et al., 2005). These pesticides
are also lipophilic, leading to their storage in the fat tissue of living
organisms (Genuis et al., 2016). Examples of persistent pesticides in-
clude the organochlorines dichlorodiphenyltrichlorethane (DDT),
chlordane, and dieldrin. Due to widespread concerns about their ad-
verse environmental effects and growing evidence of adverse health
effects, these persistent organochlorine pesticides were banned from
use in the US in the 1970's and 1980's (Agency for Toxic Substances and
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Disease Registry (ATSDR), 1994; Agency for Toxic Substances and
Disease Registry (ATSDR), 2002a; Agency for Toxic Substances and
Disease Registry (ATSDR), 2002b). In contrast, non-persistent pesticides
do not bioaccumulate in the environment, are not lipophillic, and have
shorter biological half-lives, on the order of hours to a few days
(Bradman and Whyatt, 2005). However, after the ban of persistent or-
ganochlorine pesticides in the US, residential use of the non-persistent
pesticides rose, resulting in widespread human exposure (Centers For
Disease Control). Types of non-persistent pesticides include organo-
phosphates, carbamates, pyrethroids, herbicides, and fungicides
(Centers For Disease Control).
Persistent and non-persistent pesticides may act as endocrine dis-
ruptors through their estrogenic or anti-androgenic activity and ability
to affect the estrogen or aryl hydrocarbon receptors, potential biologic
mechanisms in breast carcinogenesis (Chen et al., 2002; Du et al., 2010;
Garey and Wolff, 1998; Ghisari et al., 2015; Go et al., 1999; Klotz et al.,
1997; Medjakovic et al., 2014; Thongprakaisang et al., 2013; Welch
et al., 1969). A number of studies have examined associations between
pesticide exposures and breast cancer incidence, including those of self-
reported residential pesticide use (El-Zaemey et al., 2014; Farooq et al.,
2010; Niehoff et al., 2016; Teitelbaum et al., 2007; Zota et al., 2010),
exposure to fogger truck spray (Niehoff et al., 2016; White et al., 2013),
occupational or farmers’ wives exposure (Duell et al., 2000; El-Zaemey
et al., 2014; Engel et al., 2005, 2017), or biomarkers of organochlorine
pesticides (Charlier et al., 2003; Cohn et al., 2007, 2015; Dorgan et al.,
1999; Gammon et al., 2002b; Gatto et al., 2007; Hoyer et al., 2000b;
Krieger et al., 1994; McCready et al., 2004; Moysich et al., 1998;
Raaschou-Nielsen et al., 2005; Wolff et al., 2000; Xu et al., 2010).
Overall, the results have been mixed. A few investigations, however,
have captured exposure during peak use of DDT or during potentially
relevant windows of susceptibility and found positive associations
(Cohn et al., 2007, 2015; White et al., 2013).
Only three previous studies have examined the association of pes-
ticide exposures with survival after a diagnosis of breast cancer. Using
biomarkers of persistent, organochlorine pesticides, two observed ele-
vated breast cancer mortality (Hoyer et al., 2000a; Parada et al., 2016),
while one observed reduced breast cancer mortality (Roswall et al.,
2018). We hypothesized that self-reported residential pesticide use,
which includes persistent and non-persistent pesticides, would be as-
sociated with elevated breast cancer mortality among women with
breast cancer. Therefore, the primary aim of the study reported here
was to evaluate the association between long-term self-reported re-
sidential pesticide use and all-cause and breast cancer-specific mortality
after a breast cancer diagnosis in a population-based sample of women
who were subsequently followed for vital status.
2. Material and methods
2.1. Study design and population
This study utilized resources from the Long Island Breast Cancer
Study Project (LIBCSP), a population-based study designed to assess
environmental exposures associated with breast cancer. The parent
study was initiated as a case-control study to examine associations with
breast cancer development (Gammon et al., 2002a), and continued as a
follow-up study to assess survival (Hoyer et al., 2000a; Parada et al.,
2016). Approval for the LIBCSP was granted by the Institutional Review
Board at all participating institutions.
All women in the LIBCSP were English speaking adult residents of
Nassau and Suffolk counties in New York. Women with breast cancer
were identified from daily or weekly contact with the pathology de-
partments of 31 hospitals in Long Island and New York City, New York.
Eligible women were diagnosed between August 1, 1996 and July 31,
1997, with first primary in situ or invasive breast cancer and whose
physicians gave permission for contact. Signed informed consent and
completion of the main questionnaire was obtained for 1508 (82.1%) of
women. At diagnosis, participants ranged in age from 20 to 98 years,
were primarily postmenopausal (67%), and most reported their race as
white (94% vs. 5% black and 2% other). For the study reported here, we
excluded three women who did not answer any questions from the
pesticide section of the questionnaire, leaving 1505 for our ancillary
study.
2.2. Exposure assessment: residential pesticide use
At baseline, approximately three months after diagnosis, a 2-hour
structured questionnaire was administered to the women by trained
examiners. Factors assessed included: reproductive, menstrual, medical,
occupational, and residential histories; life course body size, physical
activity, tobacco exposure, and alcohol use; and demographics.
The residential history section asked the women about pesticides
used in or around their homes, yards, or gardens. Women reported on
15 individual categories of pesticides. Seven of the categories were used
for lawns, gardens, or plants (“weed killers”, “lawn insecticides”,
“chemicals for insects of diseases of trees”, “pesticides on a vegetable or
fruit garden”, “chemicals for insects or diseases of other outdoor
plants”, “any other type of pesticides used outdoors”, “chemicals for
diseases or bugs of indoor plants”). Eight of the categories asked about
products used to control nuisance pests (“ants, carpenter ants, or
cockroaches”, “bees or wasps”, “flies or mosquitos”, “moths, silverfish,
or caterpillars”, “mice, rats, gophers, or moles”, “fleas or ticks, except
on pets”, “termites”, “any other type of pest in your home”). For each of
these categories, women were asked how many times per year and the
number of years in their lifetime they, another household member, or a
professional exterminator applied the products. This information was
used to calculate the pre-diagnosis lifetime total number of residential
pesticide applications.
Three classifications of pesticide applications were examined:
overall (summed across all categories); each of the two combined
groups (the seven lawn and garden pesticides combined and the eight
nuisance-pest pesticides combined); and the 15 individual categories.
For overall use, the total number of lifetime pesticide applications was
categorized based quintiles of exposure among the 1505 women in this
study. For each of the two combined groups (lawn/garden and nui-
sance-pest), ever use as well as quartiles of the number of lifetime ap-
plications of that group were compared to a reference of never use of
that group. For each of the 15 individual categories of pesticides, ever
use of that category was compared to never use of the corresponding
combined group. This categorization was chosen to yield a “clean” re-
ference group, one that includes participants unexposed to all pesticides
within that group. This approach eases interpretation of the results,
where the large number of categories were all examined with the same
reference group. These classifications are similar to those used by
Teitelbaum et al. (2007) for the related study of pesticide use and breast
cancer development in the LIBCSP.
2.3. Clinical factors
Medical records were abstracted at two time points (at baseline and
again about five years later) to assess tumor characteristics (estrogen
receptor (ER) status, tumor stage, nodal involvement) and complete
course of treatment (radiation therapy, chemotherapy, and hormonal
therapy) for the first primary breast cancer. Tumor size was obtained
from the New York State Tumor Registry.
2.4. Follow-up for mortality
Women with breast cancer in the LIBCSP were followed-up for
mortality, and cause of death, using the National Death Index (NDI)
from the National Center for Health Statistics (Centers for Disease
Control and Prevention, 2014). International Statistical Classification of
Disease codes 174.9 and C-50.9 were used to identify breast cancer-
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specific deaths. Follow-up after the date of diagnosis in 1996–1997
continued until December 31, 2014. Among the 1505 women with
breast cancer included in the study reported here, there were 595
deaths from any cause (all-cause mortality) and 236 attributed to breast
cancer (breast cancer-specific mortality).
2.5. Statistical analysis
We examined the distribution of characteristics among the 1505
women with breast cancer, with participants stratified by total lifetime
number of pesticide applications (dichotomized at the median). To
assess associations between each of the pesticide classifications and all-
cause and breast cancer-specific mortality, we constructed Cox pro-
portional hazards models to estimate hazard ratios (HRs) and 95%
confidence intervals (CIs). The proportional hazards assumption was
assessed using an interaction term between covariates and time. No
violations of the assumption were observed.
Potential confounders were determined using a directed acyclic
graph (DAG) (Greenland et al., 1999; Shrier and Platt, 2008). All
models were adjusted for the minimally sufficient adjustment set that
was determined from the DAG: age, parity, education (≤high school
degree, some college, college graduate, post-college degree), race
(white, black, other), and marital status (ever/never). In this popula-
tion, tumor characteristics (stage, tumor size, nodal involvement) and
treatment (radiation therapy, chemotherapy, hormonal therapy) may
be considered on the causal pathway between residential pesticide ex-
posure and mortality, given that we previously reported a positive as-
sociation between residential pesticide use and breast cancer develop-
ment in the same study population (Teitelbaum et al., 2007). The
assumption is that pesticides cause breast cancer and, therefore, de-
termine the tumor characteristics and subsequent treatment regimen,
which in turn influence mortality. Thus, we did not include tumor
characteristics and treatment in the adjustment set, because to do so
would result in biased effect estimates (Greenland et al., 1999; Shrier
and Platt, 2008). Additionally, these characteristics are not on a con-
founding path because ER status, tumor stage, nodal involvement, or
treatment choice could not have influenced the exposure, a woman's
lifetime pesticide use. Therefore, adjustment as confounders was not
warranted.
Potential effect-measure modifiers of the pesticide-mortality asso-
ciation included: length of residence in the interview home (≥15
vs.< 15 years); BMI (≥25 vs.< 25 kg/m2); and ER status (positive vs.
negative). Although we did not consider tumor stage as a confounder,
given the importance of stage on breast cancer survival, we did consider
whether tumor size (≥2 vs.< 2mm) and nodal involvement (yes vs.
no), surrogates of tumor stage that were available in the LIBCSP,
modified the associations. To assess modification on the multiplicative
scale, stratum-specific HRs were estimated along with the ratio of ha-
zard ratios (RHRs) and corresponding 95% CIs; we also conducted log
likelihood ratio tests (LRT) from nested models with and without in-
teraction terms. To assess modification on the additive scale, single-
referent models were used to compute interaction contrast ratios (ICRs)
and corresponding 95% CIs (de Mutsert et al., 2009; Hosmer and
Lemeshow, 1992; Li and Chambless, 2007; Rothman et al., 2008).
The primary analysis examined associations for mortality outcomes
among all women with breast cancer, but a sensitivity analysis was
conducted by restricting the analyses to invasive cases alone. All ana-
lyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC).
Table 1
Participant characteristics of women with breast cancer (n=1505) in the Long Island Breast Cancer Study Project by total lifetime applications of pesticides.
Quintile 1 (< 18
applications)
Quintile 2 (18-< 56
applications)
Quintile 3 (56-< 120
applications)




n (%) n (%) n (%) n (%) n (%)
Age at diagnosis (years)
< 50 101 (33.8) 96 (31.5) 82 (27.2) 62 (20.8) 65 (21.6)
50–64 89 (29.8) 114 (37.4) 116 (38.4) 134 (45.0) 129 (42.9)
≥65 109 (36.5) 95 (31.2) 104 (34.4) 102 (34.2) 107 (35.6)
Race
White 267 (89.6) 287 (94.1) 288 (95.7) 287 (96.3) 280 (93.3)
Black 25 (8.4) 12 (3.9) 9 (3.0) 8 (2.7) 14 (4.7)
Other 6 (2.0) 6 (2.0) 4 (1.3) 3 (1.0) 6 (2.0)
Parity
Nulliparous 51 (17.1) 31 (10.2) 52 (17.2) 32 (10.7) 31 (10.3)
1 live births 37 (12.4) 43 (14.1) 32 (10.6) 28 (9.4) 26 (8.6)
2 + births 211 (70.6) 231 (75.7) 218 (72.2) 238 (79.9) 244 (81.1)
Education
≤ High school degree 158 (53.0) 145 (47.9) 145 (48.2) 138 (46.5) 133 (44.3)
Some college 66 (22.2) 70 (23.1) 80 (26.6) 66 (22.2) 77 (25.7)
College graduate 33 (11.1) 40 (13.2) 37 (12.3) 45 (15.2) 36 (12.0)
Post-college 41 (13.8) 48 (15.8) 39 (13.0) 48 (16.2) 54 (18.0)
Marital status
Never married 23 (7.7) 10 (3.3) 9 (3.0) 9 (3.0) 11 (3.7)
Ever married 276 (92.3) 295 (96.7) 293 (97.0) 289 (97.0) 289 (96.3)
Length of residence (years)
< 15 61 (21.3) 50 (17.1) 34 (11.5) 22 (7.5) 25 (8.5)
≥15 226 (78.8) 243 (82.9) 262 (88.5) 271 (92.5) 268 (91.5)
BMI at diagnosis (kg/m2)
< 25.0 142 (48.5) 148 (49.0) 144 (47.8) 125 (42.7) 124 (41.5)
25.0–29.9 86 (29.4) 99 (32.8) 91 (30.2) 103 (35.2) 97 (32.4)
≥30.0 65 (22.2) 55 (18.2) 66 (21.9) 65 (22.2) 78 (26.1)
ER status
ER- 51 (26.2) 66 (30.6) 42 (22.5) 53 (28.5) 51 (24.4)
ER+ 144 (73.6) 150 (69.4) 145 (77.5) 133 (71.5) 158 (75.6)
Stage
In situ 46 (15.4) 48 (15.7) 59 (19.5) 48 (16.1) 34 (11.3)
Invasive 253 (84.6) 257 (84.3) 243 (80.5) 250 (83.9) 267 (88.7)
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3. Results
Among this population-based sample of women with breast cancer,
those with higher total pre-diagnosis lifetime pesticide use were more
likely to have two or more live births (81.1% in quintile 5 vs. 70.6% in
quintile 1), have a college degree or higher (30.0% in quintile 5 vs.
24.8% in quintile 1), have lived in their current residence for 15 or
more years (91.5% in quintile 5 vs. 78.8% in quintile 1), and have a
BMI ≥30.0 kg/m2 (22.2% in quintile 5 vs. 22.2% in quintile 1)
(Table 1).
There was little or no association between all pesticides combined
and all-cause or breast cancer-specific mortality (Table 2). However,
ever (vs. never) use of lawn and garden pesticides was associated with a
reduced rate of all-cause mortality (HR=0.77; 95% CI= 0.63–0.95).
Similarly, quartiles 2 and 4 of pre-diagnosis lifetime applications of
lawn and garden were inversely associated with all-cause mortality
compared to never use (HR=0.74; 95% CI=0.57–0.96; HR=0.62;
95% CI=0.47–0.81, respectively; p-trend= 0.3). There was also a
suggestive inverse association between the fourth quartile of lawn and
garden applications and breast cancer-specific mortality (HR=0.65;
95% CI=0.41–1.04). There was little to no association between ever
use, or quartiles of pre-diagnosis lifetime applications, of the nuisance-
pest pesticide group, and either all-cause or breast cancer-specific
mortality.
When considering associations between the 15 individual pesticide
categories and all-cause and breast cancer-specific mortality (Table 3),
ever use for many of the individual lawn and garden pesticides was
associated with a reduced rate of all-cause mortality compared to never
use of any lawn/garden pesticides. This was found for pesticides used
for weeds, lawn insects, insects or diseases of trees, and any other type
used outdoors. HR point estimates for these categories ranged from 0.45
to 0.73. There was little to no association between individual lawn/
garden pesticides and breast cancer-specific mortality, with the excep-
tion of suggestive inverse associations for the lawn insect category.
Individual categories of nuisance-pest pesticides did not appear to be
associated with all-cause or breast cancer-specific mortality.
As shown in Table 4, lawn and garden pesticide applications were
associated with reduced all-cause mortality among women with ER
positive tumors (HR=0.66; 95% CI=0.52–0.84), but there was no
association among women with ER negative tumors (HR=1.03; 95%
CI= 0.71–1.49) (LRT pmultiplicative interaction= 0.05). The RHR for the
heterogeneity was 0.64 (95% CI=0.42–0.99). ER status did not modify
associations for overall pesticides or nuisance-pest pesticides with all-
cause mortality. Additionally, there was no modification by ER status
for any pesticide categories with breast cancer-specific mortality
(Supplemental Table 1). Neither tumor size (Supplemental Tables 2 and
3) nor nodal involvement (Supplemental Tables 4 and 5) modified the
associations between any pesticide group and all-cause or breast
cancer-specific mortality. Finally, there was no evidence of modifica-
tion by BMI or length of residence for any pesticide categories with
either all-cause or breast cancer-specific mortality (data not shown).
In sensitivity analyses, where we restricted our models to women
with invasive breast cancer, results did not differ substantially from
those shown that included both women with invasive and in situ breast
cancer (data not shown).
4. Discussion
Contrary to our study hypothesis, ever use and higher number of
pre-diagnosis lifetime applications of lawn and garden pesticides were
inversely associated with all-cause mortality. Some individual cate-
gories of lawn and garden pesticides were also inversely associated with
all-cause mortality. Further, the inverse association between lawn/
garden pesticides and all-cause mortality was observed for ER positive
tumors only. Lawn pesticides did not appear to be associated with
breast cancer-specific mortality, although precision was reduced.
Conversely, all pest groups combined and nuisance-pest pesticides were
not associated with all-cause or breast cancer-specific mortality.
Our population-based cohort study of women with breast cancer is
the first to examine self-reported residential pesticide use with survival
after breast cancer, although a previous LIBCSP study did report on the
self-reported residential pesticides with breast cancer development
Table 2
Hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between lifetime applications of pesticides and all-cause and breast cancer (BC) specific
mortality in the Long Island Breast Cancer Study Project (LIBCSP), 1996–1997.
Lifetime applications (no.) All-cause deaths (no.) All-cause mortality BC deaths (no.) BC-specific mortality
Minimum Median Maximum HR (95% CI)a HR (95% CI)a
All pest groups combined
Quintile 1 0 6 17 133 1.00 50 1.00
Quintile 2 18 34 55 117 0.99 (0.77, 1.28) 48 1.02 (0.68, 1.52)
Quintile 3 56 81 119 118 0.96 (0.74, 1.23) 51 1.12 (0.75, 1.67)
Quintile 4 120 167 240 108 0.88 (0.68, 1.15) 41 0.92 (0.60, 1.40)
Quintile 5 241 475 20,834 116 0.88 (0.68, 1.13) 44 0.95 (0.63, 1.44)
p trend= 0.4 p trend= 0.5
Lawn and garden combined group
Never used lawn and garden pesticides 129 1.00 44 1.00
Ever used lawn and garden pesticides 456 0.77 (0.63, 0.95) 189 0.87 (0.62, 1.23)
Quartile 1 1 5 15 132 0.84 (0.66, 1.08) 54 0.90 (0.60, 1.36)
Quartile 2 16 28 42 110 0.74 (0.57, 0.96) 45 0.83 (0.54, 1.28)
Quartile 3 43 71 110 121 0.91 (0.70, 1.18) 55 1.10 (0.72, 1.66)
Quartile 4 112 176 20,820 93 0.62 (0.47, 0.81) 35 0.65 (0.41, 1.04)
p trend= 0.3 p trend= 0.4
Nuisance-pest combined group
Never used nuisance-pest pesticides 50 1.00 20 1.00
Ever used nuisance-pest pesticides 535 0.90 (0.67, 1.21) 213 0.77 (0.48, 1.23)
Quartile 1 1 3 8 149 0.93 (0.67, 1.29) 58 0.81 (0.48, 1.36)
Quartile 2 9 18 38 121 0.82 (0.59, 1.16) 53 0.70 (0.41, 1.19)
Quartile 3 39 61 108 130 0.90 (0.64, 1.25) 50 0.73 (0.43, 1.25)
Quartile 4 109 330 7851 135 0.96 (0.68, 1.34) 52 0.84 (0.49, 1.44)
p trend= 0.9 p trend= 0.9
a Adjusted for age, parity, education, race, marital status, and other combined pest group (lawn/garden associations adjusted for nuisance-pest group, nuisance-
pest associations adjusted for lawn/garden group).
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(Teitelbaum et al., 2007). Three previous studies of breast cancer
mortality and pesticides examined biomarkers of the persistent orga-
nochlorine pesticides (Hoyer et al., 2000a; Parada et al., 2016; Roswall
et al., 2018). In the same LIBCSP population, the highest tertile of blood
p,p’-DDT was associated with all-cause (HR=2.19; 95% CI: 1.02–4.67)
and breast cancer-specific mortality (HR=2.72; 95% CI: 1.04–7.13) 5
years after diagnosis (Parada et al., 2016). Blood p,p’-di-
chlorodiphenyldichloroethylene (DDE), the metabolite of p,p’-DDT and
a known anti-androgen (Kelce et al., 1995), was inversely associated
with all-cause mortality (HR=0.66; 95% CI: 0.44–0.99) (Parada et al.,
2016). In a study of blood biomarker organochlorines and breast cancer
survival conducted in Denmark, dieldrin was associated with increased
all-cause (RR=2.78; 95% CI: 1.38–5.59) and breast cancer-specific
mortality (RR=2.61; 95% CI: 0.97–7.01) (Hoyer et al., 2000a). Sug-
gestive positive associations were also found for p,p’-DDT, but the
confidence intervals were imprecise due to a smaller sample size. One
study measured organochlorines in adipose tissue (Roswall et al.,
2018); p,p’-DDT and p,p’-DDE were inversely associated with all-cause
mortality (linear mortality rate ratio (MRR)= 0.89; 95% CI: 0.69–1.00
and linear MRR=0.82; 95% CI: 0.69–0.98, respectively), while diel-
drin was associated with increased mortality (linear MRR=1.22; 95%
CI: 1,05–1.41).
In contrast to these studies, our study reported here assessed pre-
diagnosis lifetime exposure to residential pesticides. Some LIBCSP
participants who were older at enrollment may have had organo-
chlorines like DDT applied residentially before those pesticides were
banned in the 1970's. However, many of the years of lifetime pesticide
application, particularly in the years closer to their breast cancer di-
agnosis in 1996 and 1997, which could be more relevant for influencing
mortality after breast cancer (Parada et al., 2016), would have been in
the period after the ban and likely instead captured non-persistent
pesticides. In 1996 the most commonly used pesticide active
Table 3
Hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between individual categories of pesticides and all-cause and breast cancer (BC) specific
mortality in the Long Island Breast Cancer Study Project (LIBCSP), 1996–1997.
Ever used pesticides for individual pest category All-cause deaths (no.) All-cause mortality BC deaths (no.) BC-specific mortality
HR (95% CI)a,b HR (95% CI)a,b
Never used any lawn and garden pesticides 129 1.00 44 1.00
Weeds 392 0.75 (0.61, 0.92) 164 0.84 (0.59, 1.19)
Lawn insects 270 0.73 (0.59, 0.91) 110 0.78 (0.54, 1.13)
Insects or diseases of trees 184 0.73 (0.58, 0.93) 77 0.84 (0.57, 1.25)
Vegetable or fruit garden pests 115 0.91 (0.70, 1.19) 48 1.01 (0.66, 1.55)
Insects or diseases of other outdoor plants 96 0.83 (0.63, 1.10) 43 1.03 (0.66, 1.61)
Any other type used outdoors 17 0.45 (0.27, 0.76) 6 0.48 (0.20, 1.15)
Diseases or bugs of indoor plants 38 0.80 (0.55, 1.16) 17 0.93 (0.52, 1.68)
Never used any nuisance-pest pesticides 50 1.00 20 1.00
Ants, carpenter ants, or cockroaches 425 0.87 (0.65, 1.18) 172 0.74 (0.46, 1.20)
Bees or wasps 215 0.87 (0.63, 1.19) 88 0.76 (0.46, 1.25)
Flies or mosquitos 123 0.95 (0.67, 1.33) 52 0.84 (0.49, 1.42)
Moths, silverfish, or caterpillars 132 0.87 (0.62, 1.22) 62 0.84 (0.50, 1.42)
Mice, rats, gophers, or moles 81 0.77 (0.54, 1.10) 36 0.72 (0.41, 1.26)
Fleas or ticks, except on pets 129 0.96 (0.68, 1.34) 62 0.85 (0.50, 1.44)
Termites 275 0.89 (0.65, 1.21) 110 0.79 (0.48, 1.29)
Any other type of pest in your home 17 0.90 (0.52, 1.58) 10 1.12 (0.51, 2.43)
a Adjusted for age, parity, education, race, marital status, and other combined pest group (lawn/garden pesticides adjusted for nuisance-pest group, nuisance-pest
pesticides adjusted for lawn/garden group).
b Each hazard ratio was determined from a separate model. A three level indicator variable was used with a common reference group: never used the combined
category of pesticides (referent), used a pesticide in the combined group but not that individual category, used the individual category (index).
Table 4
Effect measure modification by ER status for the associations between pesticide groups and all-cause mortality among breast cancer cases in the Long Island Breast
Cancer Study Project, 1996–1997.
ER status Applications of
pesticide group










ER+ > median 147 215 0.74 (0.54, 1.00) 0.03 (−0.36, 0.42) 0.98 (0.78, 1.23) 1.03 (0.67, 1.58) 0.9
≤ median 170 194 0.75 (0.55, 1.02) 1.00
ER- > median 55 69 0.96 (0.66, 1.39) 0.96 (0.66, 1.39)
≤ median 60 78 1.00 1.00
Lawn pesticides
ER+ > median 126 230 0.61 (0.44, 0.85) −0.34 (−0.82, 0.13) 0.66 (0.52, 0.84) 0.64 (0.42, 0.99) 0.05
≤ median 191 179 0.93 (0.68, 1.23) 1.00
ER- > median 57 72 1.03 (0.71, 1.49) 1.03 (0.71, 1.49)
≤ median 58 75 1.00 1.00
Nuisance-pest pesticides
ER+ > median 157 210 0.91 (0.66, 1.26) −0.21 (−0.71, 0.30) 1.10 (0.88, 1.38) 0.85 (0.55, 1.32) 0.5
≤ median 160 199 0.83 (0.60, 1.14) 1.00
ER- > median 63 69 1.29 (0.89, 1.88) 1.29 (0.89, 1.88)
≤ median 52 78 1.00 1.00
a Adjusted for age, parity, education, race, marital status, and other pesticide group.
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ingredients used in the home and garden sector were the herbicides 2,4-
dichlorophenoxyacetic acid (2,4-D), glyphosate, dicamba, and meco-
prop (MCPP) (Aspelin and Grube, 1999), all of which are considered
non-persistent (Centers For Disease Control; International Agency for
Research on Cancer (IARC), 2016; Vighi et al., 2017).
Biologically, two in vitro studies have examined the effects of a variety
of non-persistent pesticides on the ERα, androgen receptor, or aryl hy-
drocarbon receptor and found that a majority of the pesticides exhibited
agonistic effects on these receptors, and concluded that the pesticides can
act as endocrine disruptors (Ghisari et al., 2015; Medjakovic et al., 2014).
Glyphosate, the most commonly used herbicide in the US (Grube et al.,
2011), was shown to alter ERα and β expression, and demonstrate es-
trogenic activity in hormone-dependent breast cancer cells
(Thongprakaisang et al., 2013). Carbamate insecticides demonstrated
weak activation of estrogen or progesterone reported gene activity, but
acted as antagonists in the presence of 17β-estradiol or progesterone in a
study using breast cancer cell lines (Klotz et al., 1997). In two studies, two
of four pyrethroid insecticides exhibited estrogenicity (Garey and Wolff,
1998; Go et al., 1999) and all four induced cell proliferation of MCF-7
breast cancer cells (Go et al., 1999). This was consistent with an additional
study that found all of the pyrethroids examined induced MCF-7 pro-
liferation and demonstrated an ability to block the binding of estradiol to
the ER (Chen et al., 2002). In contrast, one study found that, while four of
11 compounds were ER agonists, six acted anti-estrogenically in vitro (Du
et al., 2010). Biologically, persistent pesticides have also demonstrated
endocrine disrupting effects (Zhuang et al., 2012). DDT, dieldrin, and
chlordane, have demonstrated estrogenic activity (Soto et al., 1994; Welch
et al., 1969), while DDE is an anti-androgen (Kelce et al., 1995). Ad-
ditionally, persistent pesticides may induce cell proliferation through in-
teractions with the estrogen receptors (Zhuang et al., 2012), may affect
cell invasiveness (Pestana et al., 2015), or may be stored in the adipose
tissue surrounding the tumor and affect the tumor microenvironment
(Munoz-de-Toro et al., 2006).
These experimental studies demonstrate the endocrine disrupting
potential of non-persistent and persistent pesticides, many of which
may be ER agonists. Therefore, reasons for our observation of an in-
verse association for lawn and garden pesticides, but not all pesticides
combined or nuisance-pest pesticides, with all-cause mortality after a
breast cancer diagnosis reported here are unclear. However, there is
evidence of both anti-estrogenic and estrogenic agents being associated
with increased survival after breast cancer and suggests that the me-
chanisms linking them to breast cancer survival are complex. For ex-
ample, diethylstilbestrol (DES), a high-dose estrogen, was previously
used as an endocrine treatment for breast cancer in postmenopausal
women and had similar efficacy as tamoxifen, an anti-estrogen in breast
cells, which is used today (Ingle, 2002; Ingle et al., 1981). Additionally,
although we adjusted for education as a marker of socioeconomic status
(SES), it is possible that there is residual confounding by a component
of SES that was not captured fully. For example, since only the lawn and
garden pesticides were associated with survival, perhaps the associa-
tions reflect the ability of women to reside in a house that contains a
lawn or garden, which could correlate with other factors for better
survival. However, this study was conducted using a population from
Long Island, New York where the majority of the houses are suburban
and likely have lawns.
Our study has several limitations that should be considered for the
interpretation of our results. Although the LIBCP questionnaire was
comprehensive in collecting information on 15 categories of pesticides,
it assessed general categories based on what the pesticide was used for,
but not the names of specific pesticides used. This is because during the
pilot phase of an earlier draft questionnaire, respondents who were
residents of Long Island, were unable to remember the exact names of
pesticides used in the past, but could recall the reasons for using these
chemicals (unpublished data). The implications are that multiple dif-
ferent pesticides may have been used for the same category, or a single
pesticide could have been used in multiple categories (Teitelbaum
et al., 2007). For example, a single carbamate insecticide may have
been used for “ants, carpenter ants, or cockroaches” and also for “ter-
mites.” Another limitation is that we cannot exclude the possibility of
exposure misclassification due to a woman's ability to recall long-term
pesticide use. This was less of a concern when we considered ever/
never use, compared to the lifetime number of applications, which re-
quired women to report duration and frequency of use. Any potential
misclassification based on the ability to recall pesticide use would have
been non-differential by outcome status because the information was
reported prior to mortality. Additionally, we assessed pesticide use with
a lifetime measure of number of applications as well as ever/never, but
we did not have information on the specific time period that the pes-
ticides were used by women (Teitelbaum et al., 2007). Nonetheless, it is
likely that the lifetime applications measures are adequate for ranking
women as lower vs. higher use. We also didn't consider how much
women continued to use pesticides after their diagnosis, which could be
a more relevant window of exposure for mortality and should be ex-
amined in future studies that have information on post-diagnosis use.
However, other studies in this population have found associations be-
tween pre/at-diagnosis exposures and survival after breast cancer
(Cleveland et al., 2007, 2012; Khankari et al., 2015; Parada et al., 2017;
Wang et al., 2018). Use of a few individual categories of pesticides (e.g.
“any other type used outdoors”) were less common and resulted in
smaller sample sizes and less precise estimates.
Despite these limitations, this study also had strengths. To our
knowledge, ours is the first study to examine self-reported residential
pesticide use with survival after breast cancer, addressing a potentially
important public health concern, given the fact that residential pesti-
cides are common exposures. Participants are population-based, en-
hancing the generalizability of our results. Our outcome measures, all-
cause and breast cancer-specific mortality, are of high quality because
they were ascertained using the NDI, which has high sensitivity and
specificity (Rich-Edwards et al., 1994). Additionally, we used a com-
prehensive, interviewer-administered questionnaire to assess three
groups and 15 individual categories of pesticides; this is a more detailed
assessment of these exposures than is typically encountered in epide-
miologic studies. Another strength was that participants were residen-
tially stable; 84% of the women had lived in their baseline residence for
at least 15 years. Residentially stable women may have encountered
similar pest problems over time, improving their recall of lifetime
pesticide use (Teitelbaum et al., 2007).
After a breast cancer diagnosis, women may be concerned that their
prognosis may be influenced by their past exposure to potentially
harmful environmental pollutants. Thus, it may be reassuring that the
results of this first study indicate that pre-diagnosis lifetime residential
pesticide use did not impact their survival adversely. Instead, contrary
to our study hypothesis, we observed an inverse association among
lawn and garden pesticides with all-cause mortality, and no association
with all pesticide groups combined or nuisance-pest pesticides. Future
studies are needed to confirm our findings, and should also consider
exposures after diagnosis and potential heterogeneity by race.
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